免疫疗法对非小细胞肺癌中大脑转移的益处
Narayanan Sadagopan1, Edina Komlodi-Pasztor1, Irina Veytsman1
1MedStar Georgetown Cancer Institute, Department of Hematology and Oncology, Washington, DC 20010, United States.
The oncologist
|November 15, 2024
概括
免疫疗法对患有大脑转移 (BrM) 的非小细胞肺癌 (NSCLC) 患者有希望. 较长的免疫疗法持续时间与更好的生存率相关,这表明这种难以治疗的人群的潜在治疗益处.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 免疫治疗是一种免疫疗法.
背景情况:
- 在非小细胞肺癌 (NSCLC) 中的大型大脑转移 (>2厘米) 历史上有不良结果.
- 免疫疗法在NSCLC中越来越多地使用,但其在大脑转移中的作用尚不清楚.
研究的目的:
- 为了评估免疫治疗在NSCLC患者的大脑转移的疗效.
- 在初始治疗后,评估该患者群体的生存结果.
主要方法:
- 在MedStar乔治敦癌症网络进行的回顾性研究.
- 包括36名患有大脑转移的NSCLC患者,他们在免疫治疗前接受了神经外科手术和/或放射治疗.
- 使用多变量考克斯惩罚回归分析.
主要成果:
- 内无进展生存时间 (PFS) 中位数为9.2个月;总生存时间 (OS) 中位数为31个月.
- 接受至少90天免疫治疗的患者显著改善了内PFS (HR 0.07).
- 每增加30天的免疫疗法都与改善的生存状况有关 (HR 0.77).
结论:
- 现实世界的数据表明,免疫疗法可能有利于NSCLC患者的大脑转移.
- 这一群体经常被排除在临床试验之外,这凸显了进一步研究的必要性.
- 这些发现支持探索免疫疗法,以改善具有挑战性的NSCLC脑转移病例的结果.
更多相关视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.3K
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
7.9K
相关概念视频
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
